Corvus Pharmaceuticals Inc.

NASDAQ: CRVS
Share price (1/8/25): $5.65
Market cap (1/8/25): $363 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Ownership Filter

Jones William Benton

Miller Richard a MD

Samlyn Capital, LLC

News Filter

Announces Interim Data From Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Provides Business Update and Reports Third Quarter 2024 Financial Results

Material Definitive Agreement, Financial Statements or Exhibits

Provides Business Update and Reports Second Quarter 2024 Financial Results

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC